Ad
related to: regeneron covid treatment
Search results
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
Zacks via Yahoo Finance· 3 weeks agoRegeneron Pharmaceuticals, Inc. REGN delivered lower-than-expected first-quarter 2024 results due to...
Is Regeneron's Stock in Trouble After This FDA Rejection?
Motley Fool· 11 months agoRegeneron Pharmaceuticals' (NASDAQ: REGN) sales growth has been lackluster in recent periods. The...
Regeneron (REGN) Q4 Earnings & Sales Beat, Eylea Sales Decline
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN delivered better-than-expected fourth-quarter 2022 results even...
Regeneron (REGN) Down 1.4% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for Regeneron (REGN). Shares have lost about 1.4%...
Regeneron (REGN) Outperforms YTD: What's in Store for 2023?
Zacks via Yahoo Finance· 1 year agoRegeneron Pharmaceuticals, Inc. REGN is having a good run, with shares gaining 16.4% in the year so...
Regeneron Sinks Despite Massive Earnings Beat On A Notable Blockbuster Miss
Investor's Business Daily· 2 years agoRegeneron Pharmaceuticals handily beat Wall Street's third-quarter earnings estimate Thursday, but...
If You Invested $10,000 in Regeneron Pharmaceuticals 5 Years Ago, This Is How Much You Would Have...
Motley Fool· 2 years agoRegeneron Pharmaceuticals (NASDAQ: REGN) has been a reliable, steadily growing stock over the years,...
Regeneron Sacrifices A Breakout As Competition Hammers At Its Biggest Moneymaker
Investor's Business Daily· 1 year agoThe struggles continued for Regeneron Pharmaceuticals' blockbuster eye disease treatment, Eylea, in...
If You Invested $1000 in Regeneron 10 Years Ago, This Is How Much You'd Have Now
Zacks via Yahoo Finance· 2 years agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 weeks agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron...
